Solara Active — 360° view

Solara Active, a company in the Pharmaceuticals industry, reported revenue of ₹417 crore and net profit of ₹28 crore for the September 2026 quarter.

Solara Active (NSE: SOLARA) closed at ₹628.25 on 20 Nov 2026, up 11.6% over the past year. Its market capitalisation is ₹3,049 crore and it trades at 64.4 times earnings.

Share price
₹628.25 (20 Nov 2026)
Market cap
₹3,049 Cr (20 Nov 2026)
P/E
64.42 (20 Nov 2026)
Revenue
₹417 Cr (September 2026 quarter)
Net profit
₹28 Cr (September 2026 quarter)
ROCE
4.86% (FY26)
ROE
-0.13% (FY26)
Book value
₹296 (FY26)
Dividend yield
0.00% (last 12 months to 20 Nov 2026)
52-week high / low
₹774.00 / ₹422.00 (20 Nov 2026)
1-year return
11.6% (to 20 Nov 2026)
Sector
Healthcare
Industry
Pharmaceuticals
Symbol
NSE: SOLARA

Solara Active Pharma Sciences Ltd is engaged in business of manufacturing, production, processing, formulating, sale, import, export, merchandising, distributing, trading of APIs. It was formed through demerger of API business from Strides Shasun Ltd (currently named as Stride Pharma Sciences). Subsequently, it also acquired the human API business from Sequent Scientific Ltd during the same time, making it a pure play API company.

Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.